The Equality of Women in Leading Positions of the Protestant Churches

"‘More Women in Top Positions!’ 1 – this is a claim put forward by women – and occasionally also by men – not only to the address of politics and economy, but also to church institutions. In many countries, the reason for this demand is the gap between the political and legal rights of women to be equally represented in all areas of life and work, and the reality of women to be able to get to positions of power and even more rarely to get to top leadership positions. The present paper intends to use selected examples to highlight the situation of women in senior positions of power in Protestant churches at the international level [...].", p. 150 (Introduction and Methodology)

Kurzrasenweide ganztags, halbtags oder bei begrenzter Weidefläche mit Kühen nutzen?

Mit der ökologisch geführten Milchkuhherde des Versuchs- und Bildungszentrum Landwirtschaft Haus Riswick wurden von 2009-2017 Weideversuche im Kurzrasensystem durchgeführt. Folgende Varianten wurden geprüft: Ganztagsweide (25 ha Weidefläche), Halbtagsweide (13 ha Weidefläche) und variierende Weidedauerzeiten (8 ha Weideflächen). Die tierindividuellen Milchleistungen sind bei Ganztagsbeweidung deutlich niedriger als bei Halbtagsbeweidung und variierender Weidedauer mit Stallfütterung. Die individuelle Milchleistung der Kuh kann bei Weidesystemen kein Optimierungskriterium sein. Das Weide- und Futtermanagement hat darauf abzuzielen, eine möglichst hohe Milchmenge je ha Weidefläche zu erzeugen. Steuerungsgrößen hierbei sind die Besatzstärke, die Wuchshöhe des Grases, die Weidedauer sowie die im Stall verabreichte Futtermenge. Wird an einer dieser Größen gestellt, hat dies Einfluss auf alle anderen Größen, da gegenseitige Abhängigkeiten bestehen. Die Maßnahmen sind hierbei auszurichten an eine optimale Wuchshöhe sowie an eine maximale Futteraufnahme

Conclusion

 If you search for ´transparency´ on an internet search engine, it will provide more than 87 million hits to choose from. By clicking through the results, a diverse variety of types of transparency can be found, ranging from governmental or state transparency to transparency in the financial sector to transparency in sports. While some hits provide state or corporate policies on transparency, others refer to organizations that push for increased openness of organizations. Transparency is a concept that can be applied to a broad variety of different situations and domains in our social, political and economic world, often making it difficult to grasp clearly defined conditions. Since transparency seemingly illustrates a concept with unparalleled possibilities of application, it was referred to as a ´buzzword´ throughout this volume. The contributions of this volume sought, however, to give more substance to the ‘buzzword’. In which fields of social life do matters of transparency come up? What specific role does it play? Do we understand it in an instrumental or consequential way? Who or what is at the focal point of transparency – individuals, public persons, institutions or professions? The answers to these questions, which seek to define the characteristics and criteria of transparency, and the expectations attached to the concept will differ from case to case. What is needed, therefore, is further refinement of what is actually meant when speaking about transparency. Such refinement is inevitably context-based. This is exactly what this volume aimed to do: it analyzes the concept of transparency within specific cases and attempts to show what implications it can have for individuals, politics, social media, international development aid and the pharmaceutical industry. In this regard, the approaches of our authors followed the rationale that transparency is not to be understood as a value in itself, but as instrumental in achieving specific objectives

Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children

Infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus (PVL-SA) mostly present as recurrent skin abscesses and furunculosis. However, life-threatening infections (eg, necrotizing pneumonia, necrotizing fasciitis, and osteomyelitis) caused by PVL-SA have also been reported.We assessed the clinical phenotype, frequency, clinical implications (surgery, length of treatment in hospitals/intensive care units, and antibiotic treatments), and potential preventability of severe PVL-SA infections in children.Total, 75 children treated for PVL-SA infections in our in- and outpatient units from 2012 to 2017 were included in this retrospective study.Ten out of 75 children contracted severe infections (PVL-methicillin resistant S aureus n = 4) including necrotizing pneumonia (n = 4), necrotizing fasciitis (n = 2), pyomyositis (n = 2; including 1 patient who also had pneumonia), mastoiditis with cerebellitis (n = 1), preorbital cellulitis (n = 1), and recurrent deep furunculosis in an immunosuppressed patient (n = 1). Specific complications of PVL-SA infections were venous thrombosis (n = 2), sepsis (n = 5), respiratory failure (n = 5), and acute respiratory distress syndrome (n = 3). The median duration of hospital stay was 14 days (range 5-52 days). In 6 out of 10 patients a history suggestive for PVL-SA colonization in the patient or close family members before hospital admission was identified.PVL-SA causes severe to life-threatening infections requiring lengthy treatments in hospital in a substantial percentage of symptomatic PVL-SA colonized children. More than 50% of severe infections might be prevented by prompt testing for PVL-SA in individuals with a history of abscesses or furunculosis, followed by decolonization measures

Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial.

OBJECTIVE: To assess neurocognitive function at the first-line antiretroviral therapy failure and change on the second-line therapy. DESIGN: Randomized controlled trial was conducted in 5 sub-Saharan African countries. METHODS: Patients failing the first-line therapy according to WHO criteria after >12 months on non-nucleoside reverse transcriptase inhibitors-based regimens were randomized to the second-line therapy (open-label) with lopinavir/ritonavir (400 mg/100 mg twice daily) plus either 2-3 clinician-selected nucleoside reverse transcriptase inhibitors, raltegravir, or as monotherapy after 12-week induction with raltegravir. Neurocognitive function was tested at baseline, weeks 48 and 96 using color trails tests 1 and 2, and the Grooved Pegboard test. Test results were converted to an average of the 3 individual test z-scores. RESULTS: A total of 1036 patients (90% of those >18 years enrolled at 13 evaluable sites) had valid baseline tests (58% women, median: 38 years, viral load: 65,000 copies per milliliter, CD4 count: 73 cells per cubic millimeter). Mean (SD) baseline z-score was -2.96 (1.74); lower baseline z-scores were independently associated with older age, lower body weight, higher viral load, lower hemoglobin, less education, fewer weekly working hours, previous central nervous system disease, and taking fluconazole (P < 0.05 in multivariable model). Z-score was increased by mean (SE) of +1.23 (0.04) after 96 weeks on the second-line therapy (P < 0.001; n = 915 evaluable), with no evidence of difference between the treatment arms (P = 0.35). CONCLUSIONS: Patients in sub-Saharan Africa failing the first-line therapy had low neurocognitive function test scores, but performance improved on the second-line therapy. Regimens with more central nervous system-penetrating drugs did not enhance neurocognitive recovery indicating this need not be a primary consideration in choosing a second-line regimen